Actinogen Medical Limited
ATGGF
$0.025
$0.00525.00%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -2.75% | -5.26% | |||
| Depreciation & Amortization | -2.80% | 0.59% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.75% | -19.99% | |||
| Operating Income | 2.75% | -430.43% | |||
| Income Before Tax | 2.75% | -458.30% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 2.75% | -458.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 2.75% | -458.30% | |||
| EBIT | 2.75% | -430.43% | |||
| EBITDA | 2.75% | -479.17% | |||
| EPS Basic | 0.00% | -350.00% | |||
| Normalized Basic EPS | 0.00% | -500.00% | |||
| EPS Diluted | 0.00% | -350.00% | |||
| Normalized Diluted EPS | 0.00% | -500.00% | |||
| Average Basic Shares Outstanding | 0.00% | 27.69% | |||
| Average Diluted Shares Outstanding | 0.00% | 27.69% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||